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Abstract: Conjugated fatty acids is a term given to a group of polyunsaturated fatty acids with conjugated double bonds 
systems in their carbon chains. Conjugated linolenic acids (CLnA) are present in seeds of certain plants e.g. -
eleostearic acid (cis-9, trans-11, trans-13 C18:3) in bitter melon (Momordica charantia, Cucurbitaceae) or punicic acid 
(cis-9, trans-11, cis-13 C18:3) in pomegranate (Punica granatum, Punicaceae), where usually they are most prevalent 
among fatty acids. Bitter melon and pomegranate have been widely investigated as they are commonly consumed plants 
which also have been used in traditional medicine, mainly in Asia, for treatment of many diseases, such as diabetes and 
atherosclerosis. 
The aim of this study was to evaluate the influence of a diet supplemented with an aqueous extract of bitter melon fruits 
and/or with pomegranate oil on health status and lipid profile of blood. Sprague-Dawley female rats were divided into 
four groups with different diet supplementation: pomegranate oil (G), aqueous extract of bitter melon (M), pomegranate 
oil and aqueous extract from bitter melon (M+G), and control group (C). During the experiment fasting glucose 
concentration and total cholesterol (TC), HDL, LDL, and triglyceride (TG) concentration were measured in blood 
collected intravitally from the tail vein. 
The modifications introduced into the diets did not influence negatively overall health condition of the animals. Bitter 
melon fruits extract slightly decreased the fasting glucose concentration during the experiment but its action was not 
statistically significant (p>0.05). Pomegranate oil caused an increase of fasting glucose level in G group (p=0.03657) but 
in M+G group its influence was diminished by the opposite activity of bitter melon fruits extract (p>0.05). TC was the 
lowest in G group and it did not change during the time of experiment, which can suggest that the diet supplementation 
with pomegranate oil prevents the age-related increase in cholesterol level. TC in blood of G group was significantly 
lower than in other groups in 14th (p=0.01057) and 21st (p=0.01433) weeks respectively. Aqueous extract of bitter melon 
fruits slightly diminished age-related TG increase, whereas pomegranate oil strongly prevents this tendency, as the TG 
content in G group was significantly lower than TG content in C and M groups at 14th (p=0.00060) and 21st (p=0.00003) 
week respectively. Similar activity, although not so pronounced, was visible as far as the M+G group was concerned.  
Keywords: Bitter melon, Pomegranate, Pomegranate oil, Lipid profile. 
INTRODUCTION 
Conjugated fatty acids is a term used to refer to a 
group of polyunsaturated fatty acids with conjugated 
double bonds system in their carbon chains. Amongst 
those, conjugated linoleic acids (CLA) have been 
investigated for many years due to their numerous 
health benefits, such as anti-cancerogenic, anti-
atherogenic or anti-obesity activity. They are naturally 
present, especially in ruminant fat, in rather small 
amounts (<1%) [1]. Conjugated linolenic acids (CLnA 
or super CLA) are another group of conjugated fatty 
acids which, in contrast to CLA, are present in nature in 
seeds of certain plants, where usually they are most 
prevalent among all fatty acids (>60%). Several fatty 
acids, such as -eleostearic acid (cis-9, trans-11, trans- 
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13 C18:3) from bitter melon (Momordica charantia), 
punicic acid (cis-9, trans-11, cis-13 C18:3) from 
pomegranate (Punica granatum), catalpic acid (trans-9, 
trans-11, cis-13 C18:3) from catalpa (Catalpa ovata), 
calendic acid (trans-8, trans-10, cis-12 C18:3) from pot 
marigold (Callendula officinalis), and jacaric acid (cis-8, 
trans-10, cis-12 C18:3) from jacaranda (Jacaranda 
mimosifolia), belong to CLnA group [2]. There is some 
very promising research with respect to the biological 
activities of CLnA. Especially bitter melon and 
pomegranate have been widely investigated as 
sources of CLnA, having been used in traditional folk 
medicine (mainly in Asia), for treatment of many 
diseases, such as diabetes and atherosclerosis.  
According to the World Health Organization the 
number of people suffering from diabetes and 
atherosclerosis, which often coexist, is increasing all 
over the world. Amongst the first-stage strategies for 
reducing the increase in fasting glucose levels and/or 
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cholesterol concentration in blood, changes of 
nutritional habits are recommended. In many cases 
intensive hypoglycemic therapy is necessary, despite 
the very effective outcomes of the dietary approach. On 
the other hand, many patients use alternative medicine 
therapies or dietary supplements as safe and effective 
helper of conventional drugs. Especially those with 
both blood-sugar-lowering capacity and cholesterol 
lowering capacity are of great concern. 
Momordica charantia (Cucurbitaceae) is variously 
known as bitter melon, bitter gourd, balsam pear, bitter 
apple, bitter cucumber, African cucumber, wild 
cucumber or karela [3]. It is grown in many parts of 
Asia, South America, East Africa, and the Caribbean 
and its fruits are used as a vegetable as well as a 
medicine [3, 4]. Young fruits, which are oblong and 
resemble small cucumbers, are emerald green 
whereas ripe ones are orange-yellow. They are 
traditionally recommended in Chinese and Indian 
medicine as anti-inflamatory, anti-leukemic, anti-
microbial, anti-tumor, anti-ulcer, and anti-diabetic 
agents [5]. Among the phytochemicals responsible for 
blood-glucose-lowering capacity are charantin, vicine, 
and polypeptide-p [3]. Also -eleostearic acid (of the 
CLnA family) is potentially beneficial for health. 
The pomegranate Punica granatum (Punicaceae) 
comes from the south-east part of Europe but 
nowadays it is grown in most of the countries of the 
tropical and subtropical regions of the world [6]. From 
antiquity it has been known for its multiple beneficial 
influences on health but its fruit is also consumed fresh 
or in form of juice, extract, wine or liqueur [7]. Seeds of 
pomegranate are rich in polyunsaturated fatty acids, 
among which punicic acid (cis-9, trans-11, cis-13 
C18:3) is present in the greatest amount (over 70% of 
all its fatty acids) [8]. 
The objective of the present study was to 
investigate the influence of diet supplementation with 
pomegranate seed oil and/or an aqueous extract of 
dried bitter melon fruits (bitter melon tea) on the overall 
health status, glucose levels, and lipid profiles in the 
serum of rats. 
MATERIALS AND METHODS 
Bitter Melon Aqueous Extract 
Commercially available dried fruit of bitter melon 
(Momordica charantia) (Tra Kho Qua, Gohyah Tea, 
CTE JSCO) was purchased from a local grocery store 
in Warsaw, Poland. Fresh aqueous extracts (tea) were 
prepared daily according to the manufacturer’s 
description. Briefly, water (80˚C) was added to a 
weighed amount of dried fruits to obtain 2% (w/v) 
extract. After 10 min, the extract was filtered and 
freshly cooled tea was given to animals daily.  
Pomegranate Seed Oil 
Commercially available cold pressed, unrefined oil 
from seeds of pomegranate fruits (INCI: Punica 
Granatum (Pomegranate) Seed Oil) Zielony Klub) was 
purchased from a local market (Kielce, Poland). It was 
stored in 8˚C before being given to animals. 
Animals 
The whole experiment (including the guiding 
principles for the use and care of laboratory animals) 
were approved by the Local Ethical Committee on 
Animal Experiments. Female Sprague–Dawley rats (n 
= 24, age – 30 days) were purchased from the Division 
of Experimental Animals, Department of General and 
Experimental Pathology (Medical University of Warsaw, 
Warsaw, Poland). They were kept in animal room at 
21ºC, with a 12 h light: 12 h dark cycle. During the 
entire experiment animals were fed ad libitum water 
and the standard laboratory fodder Labofeed H (Feed 
and Concentrates Production Plant, A. Morawski, 
urawia 19, Kcynia, Poland), which contains 22.0% 
protein, 4.0% fat, 30.0% starch, 5.0% fibre and 6.5% 
minerals. After 1-week adaptation, animals were 
randomly divided into 4 groups of 6 individuals each. 
The overall characteristics of each experimental group 
was as follows: 
C – control group fed a standard diet and water ad 
libitum, 
M – animals fed a standard diet and a 2% (w/v) 
aqueous extract of dried bitter melon fruits ad libitum,  
G – animals fed a standard diet and water ad libitum 
and they received pomegranate oil given via a gavage 
in the amount of 0.15 ml/day, 
M+G - animals were fed a standard diet and 2% 
(w/v) aqueous extract of dried bitter melon fruits ad 
libitum and additionally they received pomegranate oil 
given via a gavage in the amount of 0.15 ml/day. 
Supplementation of the diet was conducted for 21 
weeks. Rats were also weighed at weekly intervals to 
determine the body weight. In the 21st week of the 
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experiment all animals were decapitated and 
exsanguinated, and the weight of internal organs was 
determined. 
Glucose Analysis 
At the beginning of the experiment (week 0) and in 
the 7th, 14th and 21st weeks fasting glucose 
concentration in the blood was measured with 
CardioChekTM P.A. equipped Glucose Test Strips 
(RedMed Poland Sp. z o.o.). Blood for testing was 
collected intravitally from the tail vein. 
Lipids Analysis 
At the beginning of the experiment (week 0) and in 
the 7th, 14th and 21st weeks fasting total cholesterol 
(TC), HDL, LDL and triglyceride (TG) concentration in 
the blood were measured with CardioChekTM P.A. 
equipped with Lipid Panel Test Strips (RedMed Poland 
Sp. z o.o.). Blood for testing was collected intravitally 
from the tail vein. 
Statistical Analysis  
All data are shown as mean values ± standard 
deviation. All results were evaluated with Statistica 10.0 
(StatSoft, Poland). Results of mass gained and internal 
organs’ mass were evaluated with nonparametric 
Kruskal-Wallis test with multiple comparison test. Due 
to the accuracy of measurement method results 
obtained for glucose and lipids were tested with Q-
Dixon test followed by one way ANOVA and RIR Tukey 
post-hoc test to verify the differences among groups 
(diet) as well as Friedman ANOVA test to verify the 
results obtained during the experiment for each group 
(time). P value  0.05 was considered significant.  
RESULTS 
Applied modification of diet did not influence 
negatively overall health condition of the animals. 
Although the initial body mass of the supplemented 
animals was slightly lower than mean body mass of the 
control animals, they reached high body mass at the 
end of the experiment. Weight increase in group 
receiving water extract of bitter melon fruits (M) was the 
highest, significantly higher than in control group. 
Although mean initial body mass of animals assigned 
to the group supplemented with pomegranate oil (G) 
was the lowest and they reached the lowest end body 
mass, mass increase in this group was similar to that in 
the other groups, even slightly higher than in the C and 
M+G groups.  
We compared the influence of applied 
supplementation on the average weights of internal 
organs. Mean mass of liver and spleen did not differ 
among groups whereas the addition of pomegranate oil 
to the diet caused significant decrease of mean mass 
of kidneys and heart as the mean mass of those 
organs from the G and M+G groups was significantly 
lower than in the M group. However, when we 
compared those parameters expressed in relation to 
Table 1: Body Weight and Internal Organs Weight of Rats Supplemented with an Aqueous Extract of Dried Fruits of 
Bitter Melon and/or of Pomegranate Oil 
 
C  
(n=6) 
M 
(n=6) 
G 
(n=6) 
M+G 
(n=6) 
P value 
Mass start [g] 107.3 ± 3.9a 83.5 ± 11.8 63.0 ± 10.4a 79.2 ± 25.4 0.0024 
Mass end [g] 229.3 ± 8.9a,b 235.7 ± 10.2c,d 208.5 ± 11.3a,c 209.3 ± 10.9b,d 0.0002 
Mass increase [g]  122.0 ± 5.8a 152.2 ± 15.2a 145.5 ± 12.4 130.2 ± 16.7 0.0103 
Liver [g] 6.24 ± 0.41 6.32 ± 0.66 5.53 ± 0.81 5.77 ± 0.63 NS 
Liver [%] 2.72 ± 0.14 2.69 ± 0.36 2.64 ± 0.24 2.76 ± 0.30 NS 
Kidneys [g] 1.84 ± 0.07a,b 1.82 ± 0.08c,d 1.58 ± 0.12a,c 1.62 ± 0.12b,d 0.0002 
Kidneys [%] 0.80 ± 0.04 0.77 ± 0.03 0.76 ± 0.02 0.76 ± 0.03 NS 
Spleen [g] 0.48 ± 0.07 0.48 ± 0.03 0.49 ± 0.06 0.50 ± 0.03 NS 
Spleen [%] 0.21 ± 0.03 0.20 ± 0.01a,b 0.24 ± 0.02a 0.24 ± 0.02b 0.0078 
Heart [g] 0.82 ± 0.06 0.88 ± 0.04a,b 0.77 ± 0.03a 0.78 ± 0.04b 0.0020 
Heart [%] 0.36 ± 0.02 0.37 ± 0.02 0.37 ± 0.02 0.37 ± 0.02 NS 
All data are shown as mean values ± standard deviation. P value  0.05 - significant differences among groups in Kruskal – Wallis test; NS – not significant - P value 
> 0.05 in Kruskal – Wallis test; values sharing a letter (a, b, c, d) in one row are significantly different from each other (P  0.05) in multiple comparison test. 
4    International Journal of Cardiology and Lipidology Research, 2014, Vol. 1, No. 1 Bialek et al. 
the total body mass as a percentage of total body 
mass, only spleen weights of groups fed with 
pomegranate oil (G and M+G) were significantly higher 
than in other groups (Table 1).  
Levels of fasting glucose in the blood of all 
experimental groups during the experiment are 
presented in Table 2. Fasting glucose concentration in 
blood of the C group was the highest at the beginning 
of the experiment and it was decreasing during the 
experiment (p=0.0220). Unlimited availability of bitter 
melon fruits extract (group M) slightly decreased the 
fasting glucose concentration during the experiment but 
its action was not statistically significant (p>0.05). Diet 
supplementation with pomegranate oil caused an 
increase of fasting glucose level in the G group 
(p=0.0366) but in the M+G group its influence was 
diminished by the opposite activity of bitter melon fruits 
extract (p>0.05). However, when we compared the 
mean fasting glucose levels at the end of the 
experiment, there were no significant differences 
among all experimental groups (p>0.05). 
Changes of the total cholesterol concentration are 
given in Table 2. Total cholesterol concentration in 
blood of the C group was increasing during the 
experiment (p=0.0307). Similarly, cholesterol levels in 
Table 2: Effect of an Aqueous Extract of Dried Fruits of Bitter Melon And/or of Pomegranate Oil on Glucose Level and 
Lipid Profile in Serum 
Group P value  
C M G M+G diet 
Glucose [mg/dl] 
Week 0 91.8 ± 6.1a,b 82.2 ± 14.8c,d 60.0 ± 8.1a,c 61.3 ± 5.6b,d <0.0000 
Week 7 74.2 ± 12.6 81.8 ± 7.8 77.2 ± 3.6 72.6 ± 2.2 NS 
Week 14 67.3 ± 5.1a 68.2 ± 12.2b 88.2 ± 7.1a,b 72.2 ± 16.8 0.0149 
Week 21 66.7 ± 9.4 74.5 ± 6.0 73.8 ± 10.0 72.7 ± 10.2 NS 
TC [mg/dl] 
Week 0 146.3 ± 12.8a  133.2 ± 6.2 119.8 ± 18.4a 133.0 ± 15.6 0.0318 
Week 7 134.3 ± 8.8 136.8 ± 26.5 125.8 ± 15.4 145.7 ± 15.3 NS 
Week 14 154.3 ± 19.4a 156.5 ± 19.6b 122.0 ± 14.0a,b 152.2 ± 18.1 0.0106 
Week 21 159.2 ± 13.9a 164.8 ± 5.5b 128.3 ± 16.6a,b 148.0 ± 27.1 0.0143 
HDL [mg/dl] 
Week 0 86.7 ± 9.8a 71.5 ± 6.9a 77.0 ± 9.8 77.2 ± 8.2 0.0488 
Week 7 89.2 ± 10.7 93.0 ± 6.5 90.2 ± 11.0 92.0 ± 7.5 NS 
Week 14 84.5 ± 5.6 88.8 ± 8.1 82.7 ± 11.5 93.3 ± 10.4 NS 
Week 21 97.0 ±3.8a 95.5 ± 6.4 83.8 ± 12.8a 97.2 ±3.9 0.0237 
LDL [mg/dl] 
Week 0 46.5 ± 15.2 47.5 ± 9.0 33.7 ± 27.7 37.8 ± 10.2 NS 
Week 7 29.5 ± 15.9 19.0 ± 2.0 29.0 ± 5.5 33.8 ± 8.7 NS 
Week 14 44.5 ± 19.9 48.4 ± 14.6 83.3 ± 10.6 47.0 ± 21.2 NS 
Week 21 25.0 ± 13.1 43.5 ± 4.8 83.3 ± 11.7 12.5 ± 9.2 0.0297 
TG [mg/dl] 
Week 0 65.5 ± 9.8 70.8 ± 17.1 68.0 ± 25.7 89.7 ± 17.5  NS 
Week 7 79.0 ± 11.3 95.8 ± 19.1a 73.0 ± 10.6 77.0 ± 9.7 0.0352 
Week 14 128.8 ± 24.0a 115.2 ± 41.2b 49.2 ± 21.7a,b 97.8 ± 22.8 0.0006 
Week 21 180.7 ± 20.3a,b 138.5 ± 36.9c 87.7 ± 25.8a,c 99.0 ± 21.0b <0.0000 
All data are shown as mean values ± standard deviation. P value  0.05 - significant differences among groups in one-way ANOVA; NS – not significant - P value > 
0.05 in one-way ANOVA; values sharing a letter (a, b, c) in one row are significantly different from each other (P  0.05) in RIR Tukey test. 
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blood of rats receiving bitter melon extract as a drink 
(group M) were slightly increased during the 
experiment, reaching by the end of experiment the 
highest level of all experimental groups (164.8 ± 5.5 
mg/dl). As far as the G group is concerned, the total 
cholesterol level was the lowest in comparison with the 
other groups and it did not change during the time of 
experiment. This suggests that the diet 
supplementation with pomegranate oil prevents the 
age-related increase in cholesterol level. Total 
cholesterol content in blood of the G group was 
significantly lower than in other groups in 14th 
(p=0.0106) and 21st (p=0.0143) week respectively. 
Simultaneous supplementation of the rats’ diet with 
pomegranate oil and an aqueous extract of the dried 
fruits of bitter melon prevented the positive action of the 
pomegranate oil, as the total cholesterol content in 
blood of the M+G group did not differ from its 
concentration in the C and M groups. 
Profiles of HDL fraction concentrations in blood of 
all experimental groups is presented in Table 2. 
Content of HDL in the blood of control animals did not 
change during the experiment, and only at the end was 
slightly higher than before. The level of this fraction in 
the blood of experimental animals has increased 
significantly (p=0.0076) by the unlimited consumption 
of an aqueous extract of bitter melon fruits (group M). 
Moreover, supplementation of the diet with both bitter 
melon extract and pomegranate oil elevated HDL 
concentration (p=0.0094) even more strongly as the 
HDL content in blood of the M+G group by the 21st 
week was the highest of all experimental groups. 
However, supplementation of the rats’ diet with 
pomegranate oil (group G) only negatively influenced 
the HDL concentration and the level of this fraction was 
the lowest in blood of the G group at the end of the 
experiment (83.8 ± 12.8 mg/dl). This suggests that the 
apparent decrease of total cholesterol content caused 
by the pomegranate oil supplementation may be the 
negative effect of HDL level decreasing. 
Changes of LDL fraction profiles are presented in 
Table 2. As far as this parameter is concerned, we 
observed extremely large fluctuations among 
individuals in each experimental group. This makes it 
difficult to determine the influence of applied 
modification of diet. Due to the fact, that LDL 
concentration in blood of the G group seems to have 
been stable for the whole period of experiment, it is 
possible that pomegranate oil supplementation may 
influence the LDL concentration. 
Table 2 shows also the TG profiles of all the 
experimental groups during the experiment. 
Concentration of TG in the blood of control animals 
increased significantly with age (p=0.0007). Addition of 
aqueous extract of bitter melon fruits as a drink slightly 
diminished this tendency. However, supplementation of 
rats’ diet with pomegranate oil strongly suppresses this 
tendency, as the TG content in blood of G group was 
significantly lower than TG content in C and M groups 
at 14th (p=0.0006) and 21st (p<0.0000) week 
respectively. Similar activity but not as pronounced was 
visible as far as the M+G group was concerned. 
DISCUSSION AND CONCLUSION 
To our knowledge, this is the first study to assess 
the influence of a combined administration of 
pomegranate seed oil and bitter melon tea on health 
status in female rats. We do not report any harmful 
impact of applied diet modification on body and organ 
weight. Our observations are in accordance with those 
made by other authors. Jayasooriya et al. fed male 
Sprague-Dawley rats with diet supplemented with 
different levels of freeze dried powder of bitter melon 
for 14 days and did not observe any differences in food 
intake, body weight gain or relative liver weight in 
comparison with a control group [9]. Also in studies of 
Saha et al. who supplemented diet of rats with different 
levels of bitter gourd seed oil, no changes in body 
weight were observed [10]. Castellano et al., who fed 
piglets with the mixture of cis-9, trans-11, cis-15 C18:3 
and cis-9, trans-13, cis-15 C18:3, did not report any 
influence of such a dietary treatment for 15 days on 
body and organ weights [11]. Also Plourde et al. 
observed no differences in food intake and final body 
weight in hamsters fed with a control diet and diet 
supplemented with similar CLnA mixture [12]. However, 
male, wild-type CD-1 mice fed with a high-fat chow and 
with pomegranate seed oil (20 g oil/kg chow) reached 
significantly lower body weight (p=0.002), absolute 
weight gain (p=0.002) and percentage weight gain 
(p=0.01) compared to mice fed high-fat chow alone 
[13]. Results of Miranda et al. who fed male Wistar rats 
with a diet supplemented with 0.5% of punicic did not 
confirm this observation as they did not find any 
significant differences in final body weight between the 
experimental and control groups [14]. 
Grover et al. who summarized the potential use of 
bitter melon fruits, claimed that their consumption is 
safe with no adverse effects in most of the 
experimental models. However, abortifacient activity is 
observed as well as traditionally attributed to bitter 
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melon. Fruits and seeds seem to demonstrate grater 
toxicity than the leaves and aerial parts of a plant. 
Some adverse effects were reported in mice (reduced 
fertility, favism-like syndrome), children (hypoglycemic 
coma, convulsions) and adults (headaches) but they 
were rather rare [5]. As far as pomegranate is 
concerned, no adverse effects are attributed to its 
consumption. Randomized controlled trial of Yuan et al. 
who administered 3 g of punicic acid for 28 days to 
healthy young humans, revealed no side effects of 
such a dietary intervention [15]. Moreover, dietary 
supplements containing oil from pomegranate seeds 
and air dried or lyophilized fruits of bitter gourd are 
commercially available in many countries all over the 
world.  
Bitter melon has been widely studied with regard to 
its antidiabetic effect and many researchers confirm its 
antidiabetic and hypoglycaemic properties [5, 16]. We 
have decided to study the influence of bitter melon tea 
both on glucose level and on lipid profiles as in 
diabetes there are disturbances not only in glucose but 
also in circulating lipids levels. In diabetes transport of 
glucose into the body cells is diminished and therefore 
lipids are used much more as fuel to generate ATP. 
The lipids are made available from fat depots and this 
results in a high level of circulating lipids. Chaturvedi et 
al. administered a methanol extract of bitter melon 
fruits to albino rats for 30 days. This caused 
enhancement of oral glucose tolerance. Such a 
treatment resulted also in a significant reduction of LDL 
and TG levels (p<0.001) and in significant increase of 
HDL level (p<0.001) [17]. Also addition of bitter melon 
seed oil to the diet of diabetic rats significantly lowered 
TC and non-HDL-cholesterol levels as well as the TG 
level [18]. Jayasooriya et al. observed hypoglycaemic 
effect of bitter melon freeze-dried powder 
supplemented to rats fed with a cholesterol-free diet. 
However, these effects were reversed in rats fed a 
cholesterol-enriched diet. Dietary bitter melon also 
caused an elevation of HDL level but there was little 
effect on other serum lipid parameters [9]. On the other 
hand, Saha et al. reported an explicit action of CLnA 
isomers, as they observed normalization of TC, LDL, 
HDL and TG levels in diabetic rats [10]. Our results 
seem not to confirm this above-mentioned observation, 
as the influence of aqueous extract of bitter melon 
dried fruits on examined parameters was negligible. 
However, in our experiment there was no pathological 
condition as diabetes, which can be the main reason 
for the small impact observed by us. 
Influence of punicic acid or pomegranate seed oil on 
glucose and lipids levels in serum was also 
investigated in many experimental models, however, 
the results are not consistent. McFarlin et al. 
supplemented the high-fat diet of mice with 
pomegranate seed oil and they did not observed any 
differences in glucose concentration among the groups 
investigated. A diet modification administered for 14 
weeks also did not influence TC, TG and HDL levels 
[13]. Also Miranda et al. who modified rats diet with 
0.5% addition of punicic acid, did not observe any 
significant differences in TC, TG, HLD and non-HDL 
levels [14]. Moreover, punicic acid given to healthy 
young humans for 28 days also did not cause any 
differences in TC, TG, HDL and LDL levels [15]. 
Above-mentioned results do not confirm our 
observations, as pomegranate seed oil given to female 
Sprague-Dawley rats for 21 weeks caused distinct 
changes in their lipid profiles, especially in the TC and 
TG levels.  
This is the first report demonstrating the influence of 
separate and combined administration of pomegranate 
seed oil and bitter melon tea on health status and 
glucose and lipids levels in female rats. As our results 
are only partially in agreement with the results obtained 
by other researchers, it is necessary to extend this 
project with other experimental models, especially with 
respect to pathological processes, such as 
atherosclerosis and diabetes.  
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